Dr. Robert Mays is the Vice President of Regenerative Medicine and Head of Neuroscience Program at Athersys Inc, and an Adjunct Professor at the Case Western Reserve University School of Medicine.

His paper in the Lancet Neurology discusses his Phase II clinical trial using multipotent adult progenitor cells as a therapy for acute stroke.